The Effect of Arthroscopic Subacromial Decompression in Patients Who Are Non-responders to Non-operative Treatment.
Launched by HVIDOVRE UNIVERSITY HOSPITAL · Nov 19, 2020
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether a specific shoulder surgery, called arthroscopic subacromial decompression, is more effective than just a different type of shoulder surgery, known as glenohumeral arthroscopy, for patients who have a condition called subacromial impingement syndrome (SIS) and have not improved with other treatments. SIS often causes shoulder pain and limited movement, and this study aims to find out which approach helps patients feel better after 12 months.
To participate in this trial, patients need to have a confirmed diagnosis of SIS, have experienced shoulder pain for at least six months, and have tried physical therapy without improvement for at least three months. They also need to be considered candidates for surgery by a shoulder specialist. The trial is open to adults aged between 18 and 80, and anyone interested in participating should be able to attend follow-up appointments for rehabilitation. This study is currently recruiting participants, so if you or a loved one are dealing with persistent shoulder pain, this could be an opportunity to explore new treatment options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • SIS diagnosis (Consultant's clinical diagnosis of SIS + at least 3 out of 5 positive tests from the following: Hawkin's, Neer's, Jobe's, Painful arc and external rotation resistance test)
- • Positive subacromial injection test
- • Insidious onset of shoulder pain
- • Considered a surgical candidate by an orthopedic shoulder specialist.
- • Symptoms for at least 6 months
- • Completion of at least 3 months supervised shoulder training
- • No improvement in symptoms for at least 3 months
- • The patient must be expected to be able to attend rehabilitation and post-examinations.
- Exclusion Criteria:
- • Terminal illness or severe medical illness (ASA score higher than or equal to 4), systemic musculoskeletal disease, inflammatory joint disease (e.g. rheumatoid arthritis), symptomatic cervical spine pathology or thoracic outlet syndrome.
- • Full-thickness rotator cuff tear, calcified tendonitis, labral tear, frozen shoulder, biceps tendon pathology, acromioclavicular osteoarthrosis, glenohumeral osteoarthrosis or other concomitant shoulder pathology.
- • Previous surgery or radiotherapy on the affected shoulder.
- • Pregnancy
- • Ongoing workers compensation case or job rehabilitation process
About Hvidovre University Hospital
Hvidovre University Hospital is a leading clinical research institution located in Denmark, dedicated to advancing medical science through rigorous clinical trials and innovative healthcare solutions. As a prominent academic hospital, it integrates patient care with research, fostering collaboration among multidisciplinary teams of healthcare professionals, researchers, and academic institutions. Hvidovre University Hospital is committed to enhancing patient outcomes by conducting high-quality clinical studies across various therapeutic areas, ensuring adherence to ethical standards and regulatory compliance. Its state-of-the-art facilities and focus on translational medicine position the hospital as a key player in the development of new treatments and therapies, ultimately contributing to the improvement of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hvidovre, , Denmark
Patients applied
Trial Officials
Kristoffer Barfod, MD
Study Director
Sports Orthopedic Research Center - Copenhagen (SORC-C), Hvidovre Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials